CVE:EMH Emerald Health Therapeutics (EMH) Stock Price, News & Analysis → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free EMH Stock Alerts C$0.26 -0.01 (-3.77%) (As of 04/26/2021) Add Compare Share Share Today's RangeC$0.25▼C$0.2750-Day RangeC$0.26▼C$0.2652-Week RangeC$0.15▼C$0.53Volume384,329 shsAverage Volume644,760 shsMarket CapitalizationC$52.28 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Emerald Health Therapeutics alerts: Email Address Ad Stansberry ResearchMove Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. About Emerald Health Therapeutics Stock (CVE:EMH)Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.Read More EMH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EMH Stock News HeadlinesSeptember 23, 2023 | health.usnews.comUniversity Hospitals Elyria Medical CenterJuly 31, 2023 | finance.yahoo.comDigital Therapeutics (DTx) For Mental Health Market is Booming and Expected to Grow at a CAGR of 27.42% to 2031 | InsightAce StudyApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. July 12, 2023 | investopedia.comEfficient Market Hypothesis (EMH): Definition and CritiqueJune 20, 2023 | finance.yahoo.comRevolutionizing mental health treatment: Vistagen Therapeutics' nasal spray solutionMay 4, 2023 | health.usnews.comEmerald Care Center TulsaApril 25, 2023 | health.usnews.comEmerald ReegMarch 14, 2023 | msn.comEmerald Expositions GAAP EPS of $0.06, revenue of $93.6MApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. March 13, 2023 | sfgate.comTahoe's Emerald Bay freezes over for first time in decades amid atmospheric riverMarch 4, 2023 | venturebeat.comVisus Therapeutics to Attend TD Cowen’s 43rd Annual Health Care ConferenceJanuary 14, 2023 | finance.yahoo.comEmerald Asset Management PA, LLC 30th Annual Emerald Groundhog Day Investment Forum Opens Amid a Stormy 2023 Investment YearJanuary 4, 2023 | finance.yahoo.comEmerald Health Therapeutics Inc (TBD.BE)July 12, 2022 | finance.yahoo.comEmerald Health Therapeutics Announces Revocation of Management Cease Trade OrderJune 16, 2022 | finance.yahoo.comEmerald Health Therapeutics Provides Bi-Weekly MCTO Status UpdateMay 16, 2022 | stockhouse.comEmerald Health Therapeutics, Inc. Provides Bi-Weekly MCTO Status UpdateMay 12, 2022 | nz.finance.yahoo.comSkye Bioscience Signs Arrangement Agreement with Emerald Health TherapeuticsJanuary 5, 2022 | investing.comEmperor Oil Ltd (EMh)December 31, 2021 | ca.finance.yahoo.comStocks in play: Emerald Health Therapeutics IncDecember 31, 2021 | stockhouse.comEmerald Health Therapeutics Reports 2021 AGM ResultsNovember 29, 2021 | msn.comEmerald Health Therapeutics Leaving 'Saturated' Cannabis Market, Will Focus On PharmaceuticalsNovember 29, 2021 | finance.yahoo.comEmerald Health Therapeutics Pivots Out of Recreational and Medical Cannabis and into Pharmaceutical DevelopmentAugust 6, 2021 | news.yahoo.comEmerald Health Therapeutics Executive Chairman Avtar Dhillon ResignsSee More Headlines Receive EMH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Emerald Health Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:EMH CUSIPN/A CIKN/A Webwww.emerald.care Phone+1-250-8189838FaxN/AEmployees161Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio35.45 Current Ratio2.97 Quick Ratio2.61 Sales & Book Value Annual SalesC$13.02 million Price / Sales4.02 Cash FlowC$0.33 per share Price / Cash Flow0.78 Book ValueC$0.40 per share Price / Book0.64Miscellaneous Outstanding Shares205,028,000Free FloatN/AMarket CapC$52.28 million OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesDr. Avtar S. Dhillon (Age 59)Exec. Chairman Comp: $485.05kMr. Riaz Bandali M.B.A. (Age 51)CEO & Pres Comp: $428.21kMs. Jenn Hepburn B.B.A.CFO & Company Sec.Mr. Orville BovenschenSr. VP of OperationsMr. Bernie HertelVP of Fin. and CommunicationsMs. Rebecca WongSr. VP of Quality & Regulatory AffairsMore ExecutivesKey CompetitorsProMIS NeurosciencesTSE:PMNSmall PharmaCVE:DMTBriaCell TherapeuticsTSE:BCTMicrobix BiosystemsTSE:MBXHelix BioPharmaTSE:HBPView All Competitors EMH Stock Analysis - Frequently Asked Questions How have EMH shares performed in 2024? Emerald Health Therapeutics' stock was trading at C$0.26 at the beginning of 2024. Since then, EMH shares have increased by 0.0% and is now trading at C$0.26. View the best growth stocks for 2024 here. What other stocks do shareholders of Emerald Health Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Emerald Health Therapeutics investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA), Alibaba Group (BABA), Micron Technology (MU), CRISPR Therapeutics (CRSP), Charlotte's Web (CWBHF), Organigram (OGI), Emerald Health Therapeutics (EMHTF). How do I buy shares of Emerald Health Therapeutics? Shares of EMH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:EMH) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsMan Who Predicted 2008: “This Will be Worse.”AltimetryEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emerald Health Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
